Biotech | April 06, 2022
Singlera Genomics announces research collaboration with Astellas Pharma
The aim is to pursue methylation-based tools to better understand biological reactions to pharmaceuticals
The aim is to pursue methylation-based tools to better understand biological reactions to pharmaceuticals
GE Healthcare and Elekta aim to meet the major need for radiotherapy solutions across both developed and developing markets
Iktos and Teijin Pharma will collaborate in developing new AI technology aiming to bring further improvement and speed to the drug design process
Ind-Ra maintains a neutral outlook for healthcare in FY23
Aveir VR is specifically designed to be retrieved when therapy needs to evolve or the device needs to be replaced
Support for bioprocess, cell and gene therapy, and industry 4.0 initiatives
Trescal provides precision calibration expertise in every industry, geography and instrument across the world
It is currently available in tablet and injectable dosage forms
It also secures US $ 10 million for US launch and commercialization
Company announced that it is accelerating its investment in its Leaps by Bayer impact investment unit with more than 1.3 billion euros funding until end of 2024
Subscribe To Our Newsletter & Stay Updated
